MedPath
NMPA Approval

Lanreotide acetate for injection

H20140587

March 21, 2019

H20140587

Drug Information

注射用醋酸兰瑞肽

索马杜林

注射剂

40mg

化学药品

March 21, 2019

March 20, 2024

Company Information

Applicant Company

65,quai Georges Gorse-92100 Boulogne-Billancourt- France

Manufacturing Company

Parc d'Activités du Plateau de Signes Chemin Départemental n° 402 83870 SIGNES,FRANCE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用醋酸兰瑞肽 - NMPA 批准文号 | MedPath